The Gross Margin of Daewoong Pharma (069620.KS) is 51.60%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 51.60% |
2023-12-31 | 50.04% |
2022-12-31 | 49.91% |
2021-12-31 | 47.23% |
2020-12-31 | 42.35% |
2019-12-31 | 42.96% |
2018-12-31 | 39.75% |
2017-12-31 | 42.38% |
2016-12-31 | 42.28% |
2015-12-31 | 36.04% |